Robert Croy (left) and Bogdan Fedeles (IMAGE)

Massachusetts Institute of Technology

Robert Croy (left) and Bogdan Fedeles

Caption

MIT researchers including Robert Croy (left) and Bogdan Fedeles have discovered that a drug they originally developed as a potential cancer treatment may also hold promise in treating autosomal dominant polycystic kidney disease (ADPKD).

Credit

Melanie Gonick, MIT

Usage Restrictions

Credit must be given to the creator. No derivatives or adaptations of the work are permitted.

License

CC BY-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.